GPL Insider Trading

Insider Ownership Percentage: 44.71%
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): GBX 0

Graft Polymer Insider Trading History Chart

This chart shows the insider buying and selling history at Graft Polymer by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Graft Polymer Share Price & Price History

Current Price: GBX 0
Price Change: +0.30 (1.20%)
As of 01/14/2025 12:37 PM ET

This chart shows the closing price history over time for GPL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Graft Polymer Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/4/2024Victor BolduevInsiderSell10,750,000GBX 1£107,500
5/15/2023Alex BrooksInsiderBuy56,399GBX 5£2,819.95
See Full Table

SEC Filings (Institutional Ownership Changes) for Graft Polymer (LON:GPL)

8.19% of Graft Polymer stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Graft Polymer (UK) Plc is an innovative biotechnology company focused on developing intellectual property relating to the treatment of mental health and substance use disorders, and co-developing therapeutics for mental health disorders. Our mission is to improve outcomes for individuals suffering from these conditions, with an initial focus on trauma-related mental health disorders, such as PTSD, which affects approximately 13 million adults in the U.S. and 20 million in US, UK, and key EU markets.
Read More on Graft Polymer

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

4,146,248 shs

Average Volume

8,693,328 shs

Market Capitalization

£3.79 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.92

Who are the company insiders with the largest holdings of Graft Polymer?

Graft Polymer's top insider investors include:
  1. Victor Bolduev (Insider)
Learn More about top insider investors at Graft Polymer.